A new report, COVID-19: inpatient pharmacy utilization and outcomes examines inpatient utilization and outcomes for select medications considered as potential treatments in COVID-19 between April and July.
The COVID pandemic has produced many new challenges for hospital-based laboratories. One area that laboratory leaders may find immediate cost reduction opportunities is through a review of utilization and pricing for reference laboratory services.
This area is reserved for members of the news media. If you qualify, please update your user profile and check the box marked "Check here to register as an accredited member of the news media". Please include any notes in the "Supporting information for media credentials" box. We will notify you of your status via e-mail in one business day.